BEAT HeartBeam Inc

$BEAT down almost 50% from this week’s high of .95. Madness… it’s trading as if the FDA rescinded their priority designation…. They’re going to give a kickass presentation at the end of the month and reveal trial results that impressed the FDA so much that they responded within 30 days when they had 60 days to respond… 🍾🚀🍾🚀💰💰💰💰

$BEAT Inside buying at .80 just a few months ago, plus the possibility of a partner announcement, and FDA trials...........Holding long term

$BEAT omg 403 million shares traded today. If there’s continuation in volume we shall see $1+ this week, then the upgrades, then compliance met, then multi center trial, etc. so many things to move this up!

$BEAT lets be clear here folks. This product has the potential to save lives and impact the world. The next step relies on how positive the data is (which the signs are already pointing to it being extremely good). Once the results are out, there could be strategic partnerships in place to get this product to market. Its extremely exciting and the anticipation is all part of the fun of these volatile stocks. Im happy to invest a decent chunk in this. Lets make some money people. Lets gooooo!😎

$BEAT Glad yesterday’s rally put this one on my radar. Major catalysts ahead and plenty of upside potential. Extremely bullish! 🎯 $3

$BEAT Added more again today! What can I say? When I see this much potential, I just can't resist!

$BEAT Just so you know, if this were truly a breakthrough device, it wouldn’t be trading at $0.50. The market can be wrong, especially with penny stocks, but it’s usually not that far off.

$BEAT not only they will present ALIGN-ACS data at TCT but they will disclose HEADSTART-ACS, study of heart attack detection from 500 patients in Indonesia, in coming weeks. Stay strong, know what you own.

$BEAT 6 insiders recently acquired a combined total of almost 700,000 shares. Look it up.

$BEAT will we see an incoming partnership at the end of the month at the conference? I think we will 😎 lets goooo! Giga bullish!

$BEAT Those that keep crying dilution, the max potential dilution BEAT has is an additional 42.39 million shares for a total outstanding (possibility, not current) of 98.739 million shares. Their high over the last year was $3.44 (closing, $4.00 intraday), that equates to $1.40 a share fully diluted to match year high. And that high didn't have the FDA approval. SO I FULLY CALL BS on the dilution as a reason to be bearish. This puppy has lots of room to run!

$BEAT Branislav “brains” has a combined 30 years as a Dr and business man. He will see this through to success and sell. What a nice man. 🥊 knock it home

HeartBeam shares after the FDA granted Breakthrough Device Designation to its HeartBeam System, designed to help physicians assess potential heart-attack symptoms remotely, including in patients’ homes. The FDA granted the designation in just 30 days, ahead of its standard 60-day review period, signaling strong regulatory interest. The designation provides HeartBeam with prioritized FDA review and closer regulatory collaboration while potentially supporting accelerated Medicare coverage pathways. The company estimates a roughly $15 billion market for heart-attack assessment within a broader cardiac platform opportunity exceeding $40 billion. The designation was supported by data from the 134-patient ALIGN-ACS pilot study, with full results expected at the TCT conference later this month, providing a near-term catalyst. Shares reached an intraday high of $0.939 before paring gains, while the broader Nasdaq and S&P 500 rose 0.8% and 0.5%, respectively. $BEAT

$BEAT nice little reversal there. This wouldnt get driven down too low following the news and interest. I think we can 5x from here comfortably. My money is staying in and i will enjoy the journey with the ups and downs along the way

$BEAT new investor here, it seems that the next catalyst is TCT conference in the end of the month? This is a legit company, I will take my chances.

$BEAT COME ON, Throw the dog a bone, I would venture to say that 90% of retail are in above that 0.45 gap up. If it falls to fill that I'm gonna have way more shares that I originally wanted. lol

$BEAT FDA approved in less than 30 days. That is a significant piece in this. The standard review window is 60 days!! The volume is 370 mill already and nearly 7x the outstanding shares. That is insane. Flip all you want here under $1 but this is going to multi dollar land! 🍾🚀🍾🚀💰💰💰💰

$BEAT deadcat bounce. Won't fall for it. Waiting on .44-.45 gap fill before I add. If for whatever reason gap doesn't fill there, I am content with the amount that I hold currently. Paytience 🤌🏽

$BEAT My average is $0.62 I guess I will have to hold long term until the end of the year hopefully we see a $1 at least, $2 will be great!!

$BEAT Okay, I need this shit to get back to $.61+++ tomorrow morning so I can get the shit Out of here !!! I am done with this manipulation!! 😤😤😤